From Anthramycin to Pyrrolobenzodiazepine (PBD)-Containing Antibody-Drug Conjugates (ADCs).

From Anthramycin to Pyrrolobenzodiazepine (PBD)-Containing Antibody-Drug Conjugates (ADCs).
复制标题

DOI:
10.1002/anie.201510610
复制
发表时间:
2017-01-09
影响因子:
16.6
通讯作者:
Thurston, David E.
Thurston, David E.
中科院分区:
化学1区
文献类型:
--
作者:
Mantaj, Julia;Jackson, Paul J. M.;Rahman, Khondaker M.;Thurston, David E.

文献摘要

参考文献

被引文献

相似文献

吡咯并[2,1-c][1,4]苯二氮卓类化合物 (PBD) 是一类序列选择性 DNA 小沟结合剂,在其 C11 位和鸟嘌呤碱基的 C2-NH2 基团之间形成共价缩醛键。 PBD 单体的第一个例子,即天然产物蒽霉素,于 20 世纪 60 年代被发现,最著名的 PBD 二聚体 SJG-136(也称为 SG2000、NSC 694501 或 BN2629)于 1990 年代合成,最近已完成针对白血病和卵巢癌患者的 II 期临床试验。最近,PBD 二聚体类似物被连接到肿瘤靶向抗体上以创建抗体药物偶联物 (ADC),其中许多目前处于临床试验阶段,还有许多其他处于临床前开发阶段。这篇综述描绘了从蒽霉素到第一个 PBD 二聚体,再到含有 PBD 的 ADC 的发展,并探讨了结构-活性关系 (SAR) 和 PBD 的生物学,以及它们作为 ADC 有效负载的策略。
The pyrrolo[2,1‐c][1,4]benzodiazepines (PBDs) are a family of sequence‐selective DNA minor‐groove binding agents that form a covalent aminal bond between their C11‐position and the C2‐NH2 groups of guanine bases. The first example of a PBD monomer, the natural product anthramycin, was discovered in the 1960s, and the best known PBD dimer, SJG‐136 (also known as SG2000, NSC 694501 or BN2629), was synthesized in the 1990s and has recently completed Phase II clinical trials in patients with leukaemia and ovarian cancer. More recently, PBD dimer analogues are being attached to tumor‐targeting antibodies to create antibody–drug conjugates (ADCs), a number of which are now in clinical trials, with many others in pre‐clinical development. This Review maps the development from anthramycin to the first PBD dimers, and then to PBD‐containing ADCs, and explores both structure–activity relationships (SARs) and the biology of PBDs, and the strategies for their use as payloads for ADCs.
DOI: 10.7164/antibiotics.25.668
发表时间: 1972-01-01
影响因子: 3.3
作者:
BRAZHNIKOVA, MG;MESENTSEV, AS;KONSTANTINOVA, NV
通讯作者: KONSTANTINOVA, NV
DOI: 10.1080/15257770008033045
发表时间: 2000-01-01
影响因子: 1.3
作者:
Baraldi, PG;Cacciari, B;Gambari, R
通讯作者: Gambari, R
DOI: 10.1021/bi00358a043
发表时间: 1986-05-20
期刊: BIOCHEMISTRY
影响因子: 2.9
作者:
BARKLEY, MD;CHEATHAM, S;HURLEY, LH
通讯作者: HURLEY, LH
DOI: 10.1080/19420862.2016.1155014
发表时间: 2016-01-01
期刊: MABS
影响因子: 5.3
作者:
Feng, Yang;Wang, Yanping;Dimitrov, Dimiter S.
通讯作者: Dimitrov, Dimiter S.
DOI: 10.1016/j.jchromb.2006.04.031
发表时间: 2006-08-07
影响因子: 3
作者:
Buhrow, Sarah A.;Reid, Joel M.;Ames, Matthew M.
通讯作者: Ames, Matthew M.